A1 Refereed original research article in a scientific journal

Pancreatic imaging in MEN1-comparison of conventional and somatostatin receptor positron emission tomography/computed tomography imaging in real-life setting




AuthorsKostiainen Iiro, Majala Susanna, Schildt Jukka, Parviainen Helka, Kauhanen Saila, Seppänen Hanna, Miettinen Päivi J, Matikainen Niina, Ryhänen Eeva M, Schalin-Jäntti Camilla

PublisherOXFORD UNIV PRESS

Publication year2023

JournalEuropean Journal of Endocrinology

Journal name in sourceEUROPEAN JOURNAL OF ENDOCRINOLOGY

Journal acronymEUR J ENDOCRINOL

Volume188

Issue5

First page 421

Last page429

Number of pages9

ISSN0804-4643

DOIhttps://doi.org/10.1093/ejendo/lvad035(external)

Web address https://doi.org/10.1093/ejendo/lvad035(external)

Self-archived copy’s web addresshttps://research.utu.fi/converis/portal/detail/Publication/179777018(external)


Abstract

Objective

Pancreatic neuroendocrine tumors (panNETs) are the leading cause of death in patients with multiple endocrine neoplasia type 1 (MEN1). The role of somatostatin receptor positron emission tomography/computed tomography (SSTR PET/CT) in MEN1 has not been established. The aim was to assess pancreatic imaging in MEN1 in a real-life setting.

Design

Fifty-eight patients with MEN1 [median age 40 (range 16-72) years] underwent SSTR PET/CT imaging; either as a screening tool regardless of disease stage (n = 47) or to further characterize known panNETs (n = 11). SSTR PET/CT and matched conventional imaging were blindly analyzed. We assessed the findings and the impact of SSTR PET/CT during a median follow-up of 47 months.

Results

SSTR PET/CT detected three times as many panNETs as conventional imaging (P < .001). SSTR PET/CT altered the management of 27 patients (47%). Seven patients (12%) were referred for surgery, and five (9%) received systemic treatment. In 15/25 (60%) patients with no previous panNET (n = 22) or in remission after surgery (n = 3), SSTR PET/CT identified a panNET (n = 14) or recurrence (n = 1). In eight patients, SSTR PET/CT revealed a panNET not immediately visible on conventional imaging. During a median follow-up of 47 months, three became visible on conventional imaging, but none required intervention. When SSTR PET/CT was negative, no panNETs were identified on conventional imaging during 38 months of follow-up.

Conclusions

SSTR PET/CT demonstrates high accuracy in the detection of panNETs and alters the clinical management in nearly half of the MEN1-patients. SSTR PET/CT enables timely diagnosis and staging of MEN1-related panNETs.


Downloadable publication

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.





Last updated on 2024-26-11 at 18:12